Intravitreal bevacizumab at 4-month intervals for prevention of macular edema after plaque radiotherapy of uveal melanoma.
Shah SU, Shields CL, Bianciotto CG, Iturralde J, Al-Dahmash SA, Say EAT, Badal J, Mashayekhi A, Shields JA. Intravitreal bevacizumab at 4-month intervals for prevention of macular edema after plaque radiotherapy of uveal melanoma. Ophthalmology. 2014 Jan; 121(1):269-275.